AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2262487 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic CNS therapy (other regimens)
Number of subjects: 94
Study 2262487 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic CNS therapy
Number of subjects: 94
Study 7376944 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 0
Study 31821221 — intervention group
Group type: EXPERIMENTAL
Intervention: NEW Tx (Nutrition Exercise and Wellness Treatment)
Number of subjects: 38
Study 31821221 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 38
Study 27915580 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide Dynamic Range Compression (WDRC)
Number of subjects: 16
Study 27915580 — intervention group
Group type: COMPARATOR
Intervention: WDRC with Frequency Compression (FC)
Number of subjects: 16
Study 25631299 — intervention group
Group type: EXPERIMENTAL
Intervention: Aura-i
Number of subjects: 30
Study 25631299 — intervention group
Group type: COMPARATOR
Intervention: Intubating laryngeal mask airway
Number of subjects: 30
Study 25631299 — intervention group
Group type: COMPARATOR
Intervention: i-gel
Number of subjects: 30
Study 23757125 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial scrub type A
Number of subjects: 105
Study 23757125 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial scrub type B
Number of subjects: 105
Study 23757125 — intervention group
Group type: COMPARATOR
Intervention: Standard scrubs
Number of subjects: 105
Study 23757125 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial scrubs
Number of subjects: 105
Study 21768628 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumpatellar electrocautery
Number of subjects: 262
Study 19365010 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of tadalafil
Number of subjects: 244
Study 19365010 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of sildenafil
Number of subjects: 244
Study 19365010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 17039333 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate (0.52 mmol/kg/day in four doses)
Number of subjects: 38
Study 17039333 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 38
Study 14507122 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage with music therapy
Number of subjects: 0
Study 14507122 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage only
Number of subjects: 0
Study 14507122 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy only
Number of subjects: 0
Study 14507122 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 11104557 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaproterenol (MP) at concentrations of 10(‐8)M to 10(‐6)M
Number of subjects: 27
Study 11104557 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no MP)
Number of subjects: 27
Study 9095113 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 0
Study 9095113 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior vena cava filters (VCF)
Number of subjects: 0
Study 9095113 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study 8458056 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam regimen (2 gm every 8 hours) plus clindamycin (600 to 900 mg q8h) or nafcillin (1.5 gm to 2 gm every 6 hours)
Number of subjects: 84
Study 8458056 — intervention group
Group type: COMPARATOR
Intervention: Control regimen (aminoglycoside) including amikacin (5 mg/kg q8h) plus cefazolin (1 gm q8h) or amikacin (500 mg every 12 hours) plus mezlocillin (4 gm q6h) or tobramycin plus ticarcillin (3 gm to 4 gm q4h)
Number of subjects: 84
Study 8458056 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam regimen
Number of subjects: 84
Study 8458056 — intervention group
Group type: COMPARATOR
Intervention: Control regimen
Number of subjects: 84
Study 2429619 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen PMP (CDDP 60 mg/m2, d 1, MMC 6 mg/m2, d 3, d 10 and PEP 5 mg/m2, d 3-7)
Number of subjects: 74
Study 2429619 — intervention group
Group type: COMPARATOR
Intervention: Regimen PM (CDDP 60 mg/m2, d 1 and MMC 6 mg/m2, d 3, d 10)
Number of subjects: 74
Study 2429619 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen PMF (CDDP 60 mg/m2, d 1, MMC 6 mg/m2, d 3, d 10 and FT 800 mg/body, d 3-21)
Number of subjects: 74
Study 30243410 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and Suicide Intervention for Suicidal Teens (ASIST)
Number of subjects: 50
Study 26642949 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: two intra‐articular sacroiliac injections of local anaesthetic/corticosteroid guided by ultrasound in 7 days
Number of subjects: 60
Study 26642949 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: conventional bipolar radiofrequency 'palisade' targeting lateral branch nerves of S1, S2, and S3
Number of subjects: 60
Study 26642949 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: modified bipolar radiofrequency 'palisade' (needle distance >1cm)
Number of subjects: 60
Study 24724767 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release protein substitute
Number of subjects: 60
Study 24724767 — intervention group
Group type: COMPARATOR
Intervention: Conventional protein substitute
Number of subjects: 60
Study 22424641 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegilated‐Interferon‐alfa‐2b and ribavirin for 52 weeks
Number of subjects: 73
Study 22424641 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 73
Study 20968017 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy via the LGN‐222 quartz installation
Number of subjects: 320
Study 20968017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 320
Study 18081857 — intervention group
Group type: COMPARATOR
Intervention: PPC/DC/E (phosphatidylcholine + deoxycholate + ethanol) injected into the right posterior trochanteric areas three times at weeks 0, 3, and 6.
Number of subjects: 0
Study 18081857 — intervention group
Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 0
Study 16368850 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O 66% in the gas mixture
Number of subjects: 80
Study 16368850 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 80
Study 15622315 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 154
Study 11309186 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 100
Study 11309186 — intervention group
Group type: COMPARATOR
Intervention: Thermal‐Tactile Stimulation (TS)
Number of subjects: 100
Study 9490261 — intervention group
Group type: EXPERIMENTAL
Intervention: Repty index
Number of subjects: 40
Study 9490261 — intervention group
Group type: COMPARATOR
Intervention: Barthel Index
Number of subjects: 40
Study 7943451 — intervention group
Group type: EXPERIMENTAL
Intervention: mCPP (0.1 mg/kg)
Number of subjects: 38
Study 7943451 — intervention group
Group type: COMPARATOR
Intervention: Placebo saline
Number of subjects: 38
Study 3314794 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy
Number of subjects: 117
Study 3314794 — intervention group
Group type: COMPARATOR
Intervention: Control (no brachytherapy)
Number of subjects: 117
Study 31935166 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural Response System (RRS) intervention
Number of subjects: 2000
Study 29889239 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate (2 mg/kg/day for 5 days)
Number of subjects: 644
Study 29889239 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (25 mg base/kg over 3 days)
Number of subjects: 644
Study 29889239 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine-primaquine (0.5 mg/kg/day for 14 days)
Number of subjects: 644
Study 29889239 — intervention group
Group type: COMPARATOR
Intervention: Recurrence by day 28
Number of subjects: 644
Study 29889239 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine radical cure
Number of subjects: 644
Study 26208409 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational Soccer Program (RSP)
Number of subjects: 30
Study 26208409 — intervention group
Group type: COMPARATOR
Intervention: Obese Control Group
Number of subjects: 30
Study 23764933 — intervention group
Group type: EXPERIMENTAL
Intervention: Membrane stripping
Number of subjects: 134
Study 23764933 — intervention group
Group type: COMPARATOR
Intervention: Control (no membrane stripping)
Number of subjects: 134
Study 24378018 — intervention group
Group type: EXPERIMENTAL
Intervention: Combining community case management of malaria (CCMm) and seasonal malaria chemoprevention (SMC)
Number of subjects: 61
Study 24378018 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of malaria rapid diagnostic test (RDT)
Number of subjects: 61
Study 24378018 — intervention group
Group type: EXPERIMENTAL
Intervention: RDT and drugs stock-out
Number of subjects: 61
Study 20881066 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine 48 mg/d
Number of subjects: 79
Study 20881066 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine 96 mg/d
Number of subjects: 79
Study 20881066 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine 144 mg/d
Number of subjects: 79
Study 20881066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 20881066 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine (all doses)
Number of subjects: 79
Study 18179497 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team intervention (4 systematic assessments by a geriatrician, geriatrics advanced practice nurse, physical therapist, dietitian, and social worker during the first 9 months)
Number of subjects: 100
Study 18179497 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team intervention
Number of subjects: 100
Study 17158408 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with n-6:n-3 ratio of approximately 3:1 (enriched in alpha-linolenic acid, EPA, and DHA)
Number of subjects: 258
Study 17158408 — intervention group
Group type: COMPARATOR
Intervention: Control diet with n-6:n-3 ratio of 10:1
Number of subjects: 258
Study 14519377 — intervention group
Group type: COMPARATOR
Intervention: Hypoxic gas mixture (PET(O2)=50 mmHg)
Number of subjects: 8
Study 14519377 — intervention group
Group type: COMPARATOR
Intervention: Hyperoxic gas mixture (PET(O2)=140 mmHg)
Number of subjects: 8
Study 14519377 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 8
Study 10745254 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (D5 to D14)
Number of subjects: 43
Study 10745254 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (D5 to D14)
Number of subjects: 43
Study 10745254 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF plus G-CSF (D5-D14 and D10-D14 respectively)
Number of subjects: 43
Study 10745254 — intervention group
Group type: COMPARATOR
Intervention: G-CSF alone
Number of subjects: 43
Study 10745254 — intervention group
Group type: COMPARATOR
Intervention: GM-CSF alone
Number of subjects: 43
Study 8694202 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethylstarch solution 10% (n=15)
Number of subjects: 45
Study 8694202 — intervention group
Group type: COMPARATOR
Intervention: Human albumin 20% (n=15)
Number of subjects: 45
Study 8694202 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline continuously (1.2 mg.kg-1.h-1) (n=15)
Number of subjects: 45
Study 1286500 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (0.84 mg IV, range: 0.2 mg to 1 mg)
Number of subjects: 146
Study 1286500 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 146
Study 1286500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 1286500 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil and Placebo
Number of subjects: 146
Study 2938985 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovidol (Aaciphar SA, Brussels, Belgium)
Number of subjects: 38
Study 2938985 — intervention group
Group type: EXPERIMENTAL
Intervention: Marvelon (Organon, SA, Brussels, Belgium)
Number of subjects: 38
Study 2938985 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigynon (Schering SA, Brussels, Belgium)
Number of subjects: 38
Study 2938985 — intervention group
Group type: EXPERIMENTAL
Intervention: Desogestrel-containing preparations
Number of subjects: 38
Study 2938985 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-containing oral contraceptives
Number of subjects: 38
Study 29191052 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0
Study 29191052 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise
Number of subjects: 0
Study 29191052 — intervention group
Group type: COMPARATOR
Intervention: Stretching/Range of Motion (SROM)
Number of subjects: 0
Study 26787366 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil through inhalation
Number of subjects: 0
Study 26787366 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 0
Study 26787366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24708422 — intervention group
Group type: EXPERIMENTAL
Intervention: Materialise Mucosa
Number of subjects: 59
Study 24708422 — intervention group
Group type: COMPARATOR
Intervention: Conventional implant placement
Number of subjects: 59
Study 22402258 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based contraceptive assessment module with tailored health materials
Number of subjects: 2231
Study 22402258 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based contraceptive assessment module with generic health materials
Number of subjects: 2231
Study 22402258 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2231
Study 20381001 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise intervention (EG)
Number of subjects: 28
Study 20381001 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 28
Study 18356752 — intervention group
Group type: EXPERIMENTAL
Intervention: +LCPUFA
Number of subjects: 60
Study 18356752 — intervention group
Group type: COMPARATOR
Intervention: -LCPUFA (control)
Number of subjects: 60
Study 16043738 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic patients
Number of subjects: 1283
Study 16043738 — intervention group
Group type: EXPERIMENTAL
Intervention: African American patients
Number of subjects: 1283
Study 16043738 — intervention group
Group type: COMPARATOR
Intervention: Non-Hispanic white patients
Number of subjects: 1283
Study 12580844 — intervention group
Group type: COMPARATOR
Intervention: Low-calorie diet
Number of subjects: 74
Study 12580844 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet plus laser acupuncture
Number of subjects: 74
Study 10475411 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade/retrograde tepid blood cardioplegia (group I, n = 47)
Number of subjects: 128
Study 10475411 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade/retrograde cold blood cardioplegia with topical cooling (group II, n = 40)
Number of subjects: 128
Study 10475411 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade crystalloid cardioplegia with topical cooling (group III, n = 41)
Number of subjects: 128
Study 8622020 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (FAC: fluorouracil 600 mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 600 mg/m2)
Number of subjects: 2795
Study 8622020 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (FAC)
Number of subjects: 2795
Study 8622020 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 2795
Study 1952174 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60
Study 1952174 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 60
Study 7332915 — intervention group
Group type: EXPERIMENTAL
Intervention: guanabenz
Number of subjects: 248
Study 7332915 — intervention group
Group type: COMPARATOR
Intervention: methyldopa
Number of subjects: 248
Study 31034463 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial range of motion exercise (PRE)
Number of subjects: 44
Study 31034463 — intervention group
Group type: COMPARATOR
Intervention: Full range of motion exercise (FRE)
Number of subjects: 44
Study 27743126 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02 mg/kg midazolam (Midazolam Group)
Number of subjects: 72
Study 27743126 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control Group)
Number of subjects: 72
Study 27743126 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Midazolam and Control)
Number of subjects: 72
Study 25452229 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 964
Study 25452229 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 964
Study 24294837 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 255
Study 24294837 — intervention group
Group type: COMPARATOR
Intervention: Cognitive psychological education (CPE)
Number of subjects: 255
Study 24294837 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 255
Study 24294837 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of childhood trauma
Number of subjects: 255
Study 22950650 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's Kangaroo Care (MKC)
Number of subjects: 18
Study 22950650 — intervention group
Group type: COMPARATOR
Intervention: Alternate Female Kangaroo Care (AFKC)
Number of subjects: 18
Study 19237920 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion of packed red blood cells at thresholds of 8, 9, or 10 g/dL
Number of subjects: 30
Study 19237920 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion of packed red blood cells
Number of subjects: 30
Study 17501887 — intervention group
Group type: EXPERIMENTAL
Intervention: polyglecaprone 6211 subcuticular sutures
Number of subjects: 90
Study 17501887 — intervention group
Group type: EXPERIMENTAL
Intervention: polyglecaprone 25 subcuticular sutures
Number of subjects: 90
Study 17501887 — intervention group
Group type: EXPERIMENTAL
Intervention: staples
Number of subjects: 90
Study 15024332 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate 200 mg/day for 2 weeks, then 9-week intermission, followed by 2 weeks of etidronate
Number of subjects: 80
Study 15024332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 11579355 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheolytic thrombectomy with AngioJet device
Number of subjects: 349
Study 10738013 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI-S (metered-dose inhaler with spacer)
Number of subjects: 123
Study 10738013 — intervention group
Group type: COMPARATOR
Intervention: NEB (nebulizer)
Number of subjects: 123
Study 8986484 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-level positive airway pressure (BiPAP) for 30 min
Number of subjects: 75
Study 8986484 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) for 30 min
Number of subjects: 75
Study 8986484 — intervention group
Group type: COMPARATOR
Intervention: Routine chest physiotherapy (RCP) combined with oxygen administration via nasal cannula for 10 min
Number of subjects: 75
Study 1535592 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% plain lidocaine (n = 7)
Number of subjects: 28
Study 1535592 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine with 1/320.000 adrenaline (n = 8)
Number of subjects: 28
Study 1535592 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine with 1/800.000 adrenaline (n = 7)
Number of subjects: 28
Study 1535592 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with 1/800.000 adrenaline (n = 6)
Number of subjects: 28
Study 6432119 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (sodium restriction group)
Number of subjects: 94
Study 6432119 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic (25 mg chlorthalidone)
Number of subjects: 94
Study 6432119 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blocker (200 mg metoprolol)
Number of subjects: 94
Study 6432119 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined agent (chlorthalidone + metoprolol)
Number of subjects: 94
Study 6432119 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal diet group)
Number of subjects: 94
Study 30702985 — intervention group
Group type: EXPERIMENTAL
Intervention: RT‐IND
Number of subjects: 20
Study 30702985 — intervention group
Group type: COMPARATOR
Intervention: RT‐FIX
Number of subjects: 20
Study 29637714 — intervention group
Group type: EXPERIMENTAL
Intervention: C1 esterase inhibitor (C1INH) 50 U/kg
Number of subjects: 70
Study 29637714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 27554088 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 200 mg intravenous ibuprofen
Number of subjects: 12
Study 27554088 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 400 mg intravenous ibuprofen
Number of subjects: 12
Study 27554088 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 800 mg intravenous ibuprofen
Number of subjects: 12
Study 27554088 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of 400 mg intravenous ibuprofen (four times per day)
Number of subjects: 12
Study 24888705 — intervention group
Group type: EXPERIMENTAL
Intervention: CAL + BOP
Number of subjects: 163
Study 24888705 — intervention group
Group type: EXPERIMENTAL
Intervention: PD + BOP
Number of subjects: 163
Study 24888705 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 163
Study 22158114 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen
Number of subjects: 23
Study 22158114 — intervention group
Group type: COMPARATOR
Intervention: Breathing 21% oxygen (control condition)
Number of subjects: 23
Study 22158114 — intervention group
Group type: COMPARATOR
Intervention: Comparison of resting MSNA
Number of subjects: 23
Study 22158114 — intervention group
Group type: COMPARATOR
Intervention: Comparison of systolic BP
Number of subjects: 23
Study 22158114 — intervention group
Group type: COMPARATOR
Intervention: Comparison of diastolic BP
Number of subjects: 23